Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 9064958!ä!9064958 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Z+Kardiol 1996 ; 85 Suppl 6 (ä): 135-45 Nephropedia Template TP {{tp|p=9064958|t=1996. Magnesium als antiarrhythmisches Therapieprinzip bei supraventrikularen und ventrikularen Herzrhythmusstorungen |pdf=|usr=}}{{9064958}} gab.com Text Magnesium als antiarrhythmisches Therapieprinzip bei supraventrikularen und ventrikularen Herzrhythmusstorungen JO: Z Kardiol http://www.kidney.de/pget.php?&tw=1&pmid=9064958 #FOAvip The use of magnesium as an antiarrhythmic agent in ventricular and supraventricular arrhythmias is a matter of an increasing but still controversial discussion during recent years. With regard to the well established importance of magnesium in experimental studies for preserving electrical stability and function of myocardial cells and tissue, the use of magnesium for treating one or the other arrhythmia seems to be a valid concept. In addition, magnesium application represents a physiologic approach, and by this, is simple, cost-effective and safe for the patient. However, when one reviews the available data from controlled studies on the antiarrhythmic effects of magnesium, there are only a few types of cardiac arrhythmias, such as torsade de pointes, digitalis-induced ventricular arrhythmias and ventricular arrhythmias occurring in the presence of heart failure or during the perioperative state, in which the antiarrhythmic benefit of magnesium has been shown and/or established. Particularly in patients with one of these types of cardiac arrhythmias, however, it should be realized that preventing the patient from a magnesium deficit is the first, and the application of magnesium the second best strategy to keep the patient free from cardiac arrhythmias. Twit Text FOAVip Magnesium als antiarrhythmisches Therapieprinzip bei supraventrikularen und ventrikularen Herzrhythmusstorungen ????Z Kardiol http://www.kidney.de/pget.php?&tw=1&pmid=9064958 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=9064958 #FOAvip English Wikipedia <ref>{{Cite pmid|9064958}}</ref> Magnesium als antiarrhythmisches Therapieprinzip bei supraventrikularen und ventrikularen Herzrhythmusstorungen #MMPMID9064958 Zehender M Z Kardiol 1996[]; 85 Suppl 6 (ä): 135-45 PMID9064958show ga The use of magnesium as an antiarrhythmic agent in ventricular and supraventricular arrhythmias is a matter of an increasing but still controversial discussion during recent years. With regard to the well established importance of magnesium in experimental studies for preserving electrical stability and function of myocardial cells and tissue, the use of magnesium for treating one or the other arrhythmia seems to be a valid concept. In addition, magnesium application represents a physiologic approach, and by this, is simple, cost-effective and safe for the patient. However, when one reviews the available data from controlled studies on the antiarrhythmic effects of magnesium, there are only a few types of cardiac arrhythmias, such as torsade de pointes, digitalis-induced ventricular arrhythmias and ventricular arrhythmias occurring in the presence of heart failure or during the perioperative state, in which the antiarrhythmic benefit of magnesium has been shown and/or established. Particularly in patients with one of these types of cardiac arrhythmias, however, it should be realized that preventing the patient from a magnesium deficit is the first, and the application of magnesium the second best strategy to keep the patient free from cardiac arrhythmias. |Animals[MESH] |Anti-Arrhythmia Agents/adverse effects/*therapeutic use[MESH] |Clinical Trials as Topic[MESH] |Electrocardiography/drug effects[MESH] |Heart Conduction System/drug effects/physiopathology[MESH] |Humans[MESH] |Magnesium/adverse effects/*therapeutic use[MESH] |Tachycardia, Supraventricular/*drug therapy/etiology/physiopathology[MESH] |Tachycardia, Ventricular/*drug therapy/etiology/physiopathology[MESH]Magnesium als antiarrhythmisches Therapieprinzip bei supraventrikulare(epmc).pdf DeepDyve Pubget Overpricing